Prostate Cancer - Results from #25820

AUA 2012 - One year updated comparative cost analysis of open and robotic-assisted radical prostatectomy - Session Highlights May 20, 2012

AUA 2012 - Urinary continence (UC) and sexual function (SF) among men with localized prostate cancer treated with active surveillance (AS), radical prostatectomy (RP), and brachytherapy (PI) - Session Highlights May 20, 2012

Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance - Abstract May 18, 2012

Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro - Abstract May 18, 2012

Diffusion-weighted imaging with relative signal intensity statistical thresholding for delineating prostate cancer tumors - Abstract May 18, 2012

Active surveillance for prostate cancer: Past, present and future - Abstract May 18, 2012

Intra-fractional set-up and organ motion errors in intensity-modulated radiation therapy for prostate cancer - Abstract May 18, 2012

Prostate-specific antigen testing in older men in the USA: Data from the behavioral risk factor surveillance system - Abstract May 18, 2012

Choline PET and PET/CT in primary diagnosis and staging of prostate cancer - Abstract May 18, 2012

DWI-MRI: Single, informative, and noninvasive technique for prostate cancer diagnosis - Abstract May 18, 2012

Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective - Abstract May 18, 2012

Role of 5α-reductase inhibitors in prostate cancer prevention and treatment - Abstract May 18, 2012

External validation of the cancer of the prostate risk assessment score to predict biochemical relapse after radical prostatectomy for prostate cancer in Japanese patients - Abstract May 18, 2012

Does extended prostate needle biopsy improve the concordance of Gleason scores between biopsy and prostatectomy in the Taiwanese population? - Abstract May 18, 2012

The long-term results with delayed-combined androgen blockade therapy in local or locally advanced prostate cancer - Abstract May 18, 2012

Locally advanced prostate cancer: Three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy - Abstract May 18, 2012

Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy - Abstract May 18, 2012

Safety and tolerability of intermittent androgen deprivation therapy: A literature review - Abstract May 17, 2012

Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): Study protocol for a phase III, multicenter, randomized, controlled trial - Abstract May 17, 2012

Pathologic prostate cancer characteristics in patients eligible for active surveillance: A head-to-head comparison of contemporary protocols - Abstract May 17, 2012

Page 1292 of 1435